2025 annual financial data
Indivior Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 10,400%.
Operating income was 265,000,000 USD and net income was 210,000,000 USD.
Operating cash flow was -27,000,000 USD.
Get free Indivior Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,239,000,000 USD
- Operating income
- 265,000,000 USD
- Net income
- 210,000,000 USD
- Operating cash flow
- -27,000,000 USD